# FDA 483 - Tooraj J. Raoof, M.D. - August 02, 2019

Source: https://www.keypedia.com/records/483/tooraj-j-raoof-md/4891da1c-ef2b-49fe-bee3-f6c67f576c15

> FDA 483 for Tooraj J. Raoof, M.D. on August 02, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Tooraj J. Raoof, M.D.
- Inspection Date: 2019-08-02
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Tooraj J. Raoof, M.D., a clinical investigator in Encino, CA, revealed significant deviations from investigational plans and study protocols for two human clinical studies involving investigational drugs. The firm failed to ensure subject eligibility criteria were met and conducted numerous out-of-window study visits without sponsor approval, compromising data integrity and subject safety.

## Related Officers

- [investigator](https://www.keypedia.com/people/sherri-n-rohlf/41090ab1-83d1-4e95-92ea-0cfca5cecdb6)

Company: https://www.keypedia.com/companies/tooraj-j-raoof-md/33f45aed-0f52-4e09-9d15-74b28a967dc9

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6